From online forums to the clinic, people have reported that diabetes and weight-loss drugs such as Ozempic and Wegovy can ...

The effect was seen across a wide variety of addictive and habit-forming substances, including cocaine, opioids, alcohol, ...

The blockbuster GLP-1 drugs that have reshaped the treatment of diabetes and obesity may help prevent multiple substance use ...

Patients with type 2 diabetes who received sodium-glucose cotransporter-2 inhibitors demonstrated a nearly 50% lower risk for systemic autoimmune rheumatic disease vs. those who received dipeptidyl ...

By Nancy Lapid March 4 (Reuters) - Ozempic, Mounjaro and other GLP-1 drugs for diabetes can prevent new substance use ...

A large study of US veterans suggests that diabetes and weight-loss medicines may curb cravings and lower severe addiction outcomes, though clinical trials are still needed.

A patient of mine, a veteran who had tried to quit smoking for over a decade, told me that after he started a GLP-1 drug for ...

The search for long COVID treatments continues, as a randomized clinical trial found that a two-week course of metformin or ursodeoxycholic acid (UDCA) did not meaningfully improve recovery from ...

Weight-loss drugs may prevent deadly heart complications by opening blocked blood vessels after heart attacks, groundbreaking new research reveals.

Once used exclusively for managing diabetes, celebrities' use of weight loss medications like Ozempic, Mounjaro, Wegovy, ...

New research suggests the weight-loss medications could be powerful tools in tackling substance use disorders.

GLP-1 medications may quiet the brain signals behind addiction, reducing substance use disorders and overdose risk across ...